Skip to nav Skip to content

Gallbladder cancer can be challenging to detect early because it may not cause noticeable symptoms until the tumor has grown larger. In some cases, it is discovered unexpectedly when the gallbladder is removed to treat another condition, such as gallstones. In other cases, gallbladder cancer is identified after symptoms such as abdominal pain or jaundice lead to imaging and additional testing.

If you’ve been diagnosed with gallbladder cancer, our specialists are here to guide you with expert, personalized care.
Get Expert Guidance for Gallbladder Cancer

A patient with suspected or confirmed gallbladder cancer can receive a comprehensive evaluation through the Gastrointestinal Oncology Program at Moffitt Cancer Center. Our surgeons, medical oncologists, radiation oncologists, radiologists, pathologists and other specialists will work together as a multispecialty team to establish an accurate diagnosis and develop an individualized treatment plan based on the cancer’s stage, pathology and molecular characteristics.

Quick facts: diagnosing gallbladder cancer

  • Gallbladder cancer is often discovered incidentally. There is no routine screening test for people at average risk. Some tumors are initially detected when the gallbladder, removed during a cholecystectomy for gallstones or another benign condition, is evaluated by a pathologist.
  • Pathology confirms the diagnosis. A pathologist examines suspicious tissue to determine whether cancer is present and characterize the tumor. However, a needle biopsy is not always necessary before surgery. If imaging suggests that a gallbladder tumor can be surgically removed, the healthcare team may recommend surgery first, with the removed tissue then examined to confirm the diagnosis.
  • Imaging helps determine the cancer’s extent. Ultrasound, computed tomography (CT) and magnetic resonance imaging (MRI) can help define the tumor’s location, evaluate its relationship to the liver and nearby structures and look for cancer in lymph nodes or distant organs.
  • Molecular testing can help guide treatment for advanced gallbladder cancer. Tumor profiling may identify biomarkers such as HER2 alterations or other molecular changes that can help determine whether certain targeted therapies, immunotherapies or clinical trials may be appropriate.

How gallbladder cancer is diagnosed

No single test provides all the information needed to evaluate suspected gallbladder cancer. Instead, the evaluation may begin with a review of the patient’s symptoms and medical history and a physical examination before proceeding to blood tests, imaging and other diagnostic procedures.

The sequence of diagnostic testing can vary considerably from one patient to another. For example, a patient with jaundice may initially undergo blood tests and an abdominal ultrasound, while a patient whose cancer is discovered after gallbladder surgery may already have a definitive pathology diagnosis and require additional imaging to determine the extent of the disease.

Laboratory and blood tests used to diagnose gallbladder cancer

Blood testing alone cannot confirm gallbladder cancer, but blood work can provide important information about the liver, gallbladder and bile ducts, which together make up much of the biliary system. The liver produces bile, a digestive fluid that helps the body break down and absorb fats, while the gallbladder stores and releases bile into the small intestine through the bile ducts. Abnormal blood test results can indicate that bile flow or liver function has been affected, helping the healthcare team determine whether additional testing is needed.

Lab tests commonly used during the diagnostic process for gallbladder cancer include:

  • Liver function tests – Measurements of bilirubin, alkaline phosphatase and liver enzymes in the blood can reveal abnormalities associated with inflammation or blockage of the biliary system. Bilirubin is a yellow substance produced when red blood cells break down. It is normally processed by the liver and excreted in bile, but it can build up in the blood and cause jaundice when bile flow is obstructed. Alkaline phosphatase is an enzyme found in several tissues, including the liver and bile ducts. Its level may also rise when bile flow is obstructed.
  • Complete blood count (CBC) – This lab test measures red blood cells, white blood cells and platelets. The results can provide a broader picture of the patient’s health before a diagnostic procedure or treatment.
  • Blood chemistry tests – A comprehensive metabolic panel (CMP) or other blood chemistry testing may be used to evaluate liver and kidney function and identify abnormalities that could affect imaging, procedures or treatment planning.

Abnormal blood test results can support the need for further evaluation but cannot distinguish gallbladder cancer from other liver, gallbladder or bile duct conditions with certainty. 

NCI Comprehensive Cancer Center badgeFlorida's Largest NCI Cancer Center

Recognized as a leader in cancer excellence, Moffitt is the state's largest National Cancer Institute-designated Comprehensive Cancer Center by cancer patient volumes.

Schedule an Appointment

Tumor markers used to evaluate gallbladder cancer

Two blood-based tumor markers that may be measured in a patient with suspected or confirmed gallbladder cancer are CA 19-9 and carcinoembryonic antigen (CEA). While some gallbladder cancers can cause the levels of these substances to become elevated in the bloodstream, neither marker is specific enough to confirm a diagnosis. CA 19-9 and CEA can also be elevated with other cancers and certain noncancerous conditions. For example, CA 19-9 levels can rise when the bile ducts are inflamed or obstructed. The levels also may not rise until gallbladder cancer becomes advanced. If a marker is elevated at the time of diagnosis, the healthcare team may follow the level over time along with imaging and other clinical information to assess the disease.

Imaging tests used to diagnose gallbladder cancer

Imaging plays a central role in evaluating suspected gallbladder cancer. In addition to identifying an abnormality, imaging can help determine whether the tumor has extended into the liver or other nearby structures, involved lymph nodes or spread to distant areas.

Depending on the clinical situation, testing may include:

  • Abdominal ultrasound – Often one of the first imaging tests performed for symptoms such as right upper abdominal pain or jaundice, ultrasound uses high-frequency sound waves to create images of the gallbladder, liver and nearby structures. It can identify abnormalities such as a mass or thickening of the gallbladder wall without exposing the patient to radiation.
  • Computed tomography (CT) – Detailed cross-sectional images can show a gallbladder tumor and its relationship to the liver, nearby lymph nodes, blood vessels and other organs. CT can therefore contribute to both diagnosis and staging and may help determine whether surgery is feasible.
  • Magnetic resonance imaging (MRI) – MRI provides detailed images of soft tissues and can help characterize abnormalities involving the gallbladder, liver and surrounding structures.
  • Magnetic resonance cholangiopancreatography (MRCP) – This specialized type of MRI provides detailed images of the bile ducts without requiring an endoscope. It may be useful when the healthcare team needs to determine whether a tumor is affecting or obstructing the biliary system.
  • Endoscopic ultrasound (EUS) – During EUS, a thin, flexible endoscope with an ultrasound probe is passed through the mouth and digestive tract, allowing the probe to obtain detailed images of the gallbladder. EUS can help evaluate the tumor and nearby lymph nodes and, in selected cases, facilitate tissue sampling.
  • Positron emission tomography (PET), often combined with CT – PET/CT is not necessary for every patient, but it may be used in selected cases to look for areas of cancer that have spread beyond the gallbladder and could influence treatment planning.

The healthcare team selects appropriate imaging studies based on what is already known about the suspected cancer and the specific questions that need to be answered.

Patient talking to a nurse on a MRI tomography at hospital stock photo

Procedures and biopsies used to diagnose gallbladder cancer

Pathological examination of tissue is used to confirm a gallbladder cancer diagnosis. An important distinction, however, is that not every patient needs a biopsy before surgery. If imaging strongly suggests a gallbladder tumor that appears removable, the healthcare team may recommend proceeding directly to surgery rather than inserting a needle into the tumor to obtain a tissue sample. The removed gallbladder and other tissue can then undergo detailed pathological examination.

If additional evaluation or tissue sampling is necessary, the diagnostic process may include:

  • Endoscopic retrograde cholangiopancreatography (ERCP) – A flexible endoscope is inserted through the mouth and guided into the first part of the small intestine. Special instruments can then be passed through the scope and into the bile ducts, allowing the physician to identify and relieve a bile duct obstruction or collect tissue for examination by a pathologist.
  • Endoscopic ultrasound – In addition to producing detailed images, EUS may allow the physician to guide a needle into a suspicious lesion or lymph node to obtain a sample when tissue confirmation is needed.
  • Percutaneous transhepatic cholangiography (PTC) – In selected patients, a needle is passed through the skin and liver into a bile duct to inject contrast dye and evaluate an obstruction. PTC may also allow bile or cells to be collected and can be used to help restore bile flow when necessary.
  • Diagnostic laparoscopy – Performed under general anesthesia through small abdominal incisions, laparoscopy allows the surgeon to directly examine the gallbladder, liver and surrounding abdominal structures. It may help identify small areas of spread that were not apparent on imaging and allow suspicious tissue to be sampled.

When a separate biopsy is appropriate, the method depends on the tumor’s location, whether the cancer appears to be removable and the purpose of obtaining tissue. Options may include:

  • Fine needle aspiration (FNA) – A very thin needle is guided into a suspicious tumor or lymph node, usually with CT or ultrasound guidance, to withdraw cells for laboratory examination. Local anesthetic is typically used to numb the skin before the procedure.
  • Core needle biopsy – A slightly larger hollow needle removes a small cylinder of tissue, providing the pathologist with more tissue architecture to examine than an FNA generally provides. Imaging guidance helps the physician precisely position the needle.
  • Surgical tissue sampling – Tissue can be collected during laparoscopy or another operation. When gallbladder cancer is discovered after a cholecystectomy, the removed gallbladder itself provides the tissue needed for pathological diagnosis.

Because the optimal approach differs depending on whether the tumor appears surgically removable, biopsy decisions are carefully individualized.

Molecular and biomarker testing for gallbladder cancer

A tissue sample can provide information beyond whether cancer is present. Moffitt’s pathologists can evaluate the tumor’s microscopic features and, when appropriate, perform molecular and biomarker testing that may reveal characteristics relevant to treatment.

For a patient with advanced gallbladder cancer, comprehensive molecular profiling can be particularly important. Testing may evaluate HER2, which is altered in a subset of biliary tract cancers and appears to be particularly relevant in gallbladder cancer, as well as other molecular changes that may help guide treatment. Testing for microsatellite instability (MSI) or mismatch repair deficiency (dMMR) can also help identify patients who may benefit from certain immunotherapies.

These findings can help the healthcare team determine whether a targeted therapy, immunotherapy or molecularly selected clinical trial may be appropriate. The specific tests ordered depend on the stage of the cancer, available tissue and how the results could affect treatment decisions.

Three things to do after being diagnosed with gallbladder cancer

Receiving a gallbladder cancer diagnosis can bring many questions about what happens next. Although each patient’s situation is different, several practical steps can help the patient prepare for discussions about staging and treatment. For instance, it may be helpful to:

  1. Build a support system – Trusted family members and friends can provide emotional and day-to-day support throughout evaluation and treatment. A patient may also choose to bring someone to appointments to listen, take notes and help keep track of information.
  2. Learn about the diagnosis and treatment options – Understanding the cancer’s type, stage and relevant biomarkers can make conversations with the healthcare team easier to follow. Because gallbladder cancer is uncommon, consultation with specialists who routinely evaluate gastrointestinal and hepatobiliary cancers can be especially valuable.
  3. Prepare questions for the healthcare team – General information can provide useful background, but treatment recommendations need to reflect the individual patient’s diagnosis. Writing down questions about pathology findings, stage, additional testing, surgery, systemic therapy, radiation therapy and clinical trials can help the patient make the most of each appointment.

Frequently asked questions (FAQs) about gallbladder cancer diagnosis

Gallbladder cancer can be diagnosed through several different pathways, so the patient may encounter different tests depending on how the abnormality was initially found. The answers below address several common questions about the process.

How is gallbladder cancer usually discovered?

Gallbladder cancer may be found after symptoms such as jaundice or right upper abdominal pain prompt diagnostic imaging. It is also sometimes discovered incidentally after the gallbladder is removed during surgery for gallstones or another noncancerous condition and the removed tissue is examined by a pathologist. There is no routine gallbladder cancer screening test recommended for routine use in the general population.

Can an ultrasound definitively diagnose gallbladder cancer?

No. An abdominal ultrasound can identify a suspicious mass, abnormal gallbladder wall thickening or other findings that warrant further investigation, but imaging alone generally cannot provide definitive pathological confirmation of cancer. Additional imaging and microscopic examination of tissue or cells may be necessary.

What blood tests are used to check for gallbladder cancer?

Blood tests may include bilirubin and liver function tests, which can identify abnormalities associated with the gallbladder, liver or bile ducts. CA 19-9 and CEA tumor markers may also be measured, but neither is specific enough to diagnose gallbladder cancer on its own.

Is a biopsy always necessary before gallbladder cancer surgery?

No. If imaging shows a suspicious gallbladder tumor that appears removable, the healthcare team may recommend surgery without first performing a needle biopsy. The removed gallbladder is then examined by a pathologist to establish the diagnosis and obtain additional information about the cancer.

What happens if gallbladder cancer is found unexpectedly after gallbladder removal?

A pathologist examines the removed gallbladder to determine how deeply the tumor has grown and assess other microscopic features. The patient may then undergo imaging and specialist evaluation to determine the extent of the cancer and whether additional surgery or another treatment should be considered.

The Moffitt Cancer Center difference for diagnosing gallbladder cancer

Because gallbladder cancer is relatively uncommon and may be discovered unexpectedly, an accurate pathological diagnosis and careful assessment of the tumor’s extent are particularly important. Moffitt’s Gastrointestinal Oncology Program brings together specialists in surgery, medical oncology, radiation oncology, gastroenterology, pathology, diagnostic imaging and interventional radiology to evaluate gastrointestinal cancers and coordinate individualized care. Moffitt also offers advanced endoscopy, specialized radiology interpretation, molecular therapies and clinical trials through its comprehensive gastrointestinal oncology services.

A patient who has already received a diagnosis elsewhere can also come to Moffitt for a second opinion. Pathologists with expertise in gastrointestinal cancers can review tissue from a previous biopsy or surgery to verify the diagnosis and characterize the tumor, while specialized radiologists can review imaging to help clarify the cancer’s location and extent. When appropriate, additional molecular testing can provide information about the tumor’s biology that may influence treatment options.

Moffitt is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center known for groundbreaking research and a robust portfolio of clinical trials. Our patients benefit from the expertise of specialists who are familiar with uncommon gastrointestinal cancers such as gallbladder cancer as well as emerging approaches to diagnosis and treatment. 

To learn more about diagnosing gallbladder cancer, you can request an appointment with a specialist in Moffitt’s Gastrointestinal Oncology Program by calling 1-888-663-3488 or submitting a new patient registration form online. We do not require referrals.